Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Calgary
$100,000.00
Determining the mechanisms of innnate immune responses to intracerebral (IC) oncolytitc viruses (OV).
FY 2008-09
Summary
Brain tumors are one of the most fatal kinds of cancer. Even with the best available treatments, patients with malignant brain tumors only live a year on average! Clearly there is a need to develop better treatments for our patients. One kind of new experimental therapy uses viral infections to infect and kill cancer cells. We call this approach "oncolytic virus" therapy. These viruses have produced remarkable results in the laboratory, but when tested in patients, although safe, the outcomes have been disappointing. The viruses we use are either naturally occurring ("wild type"), grown to adopt certain properties ("selected"), or engineered genetically to improve their safety and/or effectiveness. We believe that the greatest limitation of these viruses is the immune system in patients. So our goal is to understand the immune responses to these viruses in tumour cells versus normal cells. By doing this we will be able to selectively impair the tumour cells ability to resist the virus without reducing the ability of the normal cells in the body to resist infection. While a great deal is known about how the normal cells in the body fight viral infections, less is known about how the brain fights viruses when they are introduced directly into the brain (this does not occur in everyday life, but is necessary for brain cancer oncolytic treatment). Even less is known about the immune defects in cancer cells that allow them to support a vibrant and lethal viral infection. Our studies here will aim to uncover some of these answers. By studying the mechanisms of how the brain fights and removes viruses when they are injected directly into the brain, we hope to identify areas of the infection fighting process that can be changed to improve the viral infection of cancer cells without changing the normal body's ability to fight infection. By doing so, we may be able to use oncolytic therapy with certain drugs that may be able to better treat brain cancer patients.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
184589
Name
Zemp Franz J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Determining the mechanisms of innnate immune responses to intracerebral (IC) oncolytitc viruses (OV).
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Brain Cancer Therapy; Oncolytic Viral Therapy; Viral Immune Response
Abstract
Brain tumors are one of the most fatal kinds of cancer. Even with the best available treatments, patients with malignant brain tumors only live a year on average! Clearly there is a need to develop better treatments for our patients. One kind of new experimental therapy uses viral infections to infect and kill cancer cells. We call this approach "oncolytic virus" therapy. These viruses have produced remarkable results in the laboratory, but when tested in patients, although safe, the outcomes have been disappointing. The viruses we use are either naturally occurring ("wild type"), grown to adopt certain properties ("selected"), or engineered genetically to improve their safety and/or effectiveness. We believe that the greatest limitation of these viruses is the immune system in patients. So our goal is to understand the immune responses to these viruses in tumour cells versus normal cells. By doing this we will be able to selectively impair the tumour cells ability to resist the virus without reducing the ability of the normal cells in the body to resist infection. While a great deal is known about how the normal cells in the body fight viral infections, less is known about how the brain fights viruses when they are introduced directly into the brain (this does not occur in everyday life, but is necessary for brain cancer oncolytic treatment). Even less is known about the immune defects in cancer cells that allow them to support a vibrant and lethal viral infection. Our studies here will aim to uncover some of these answers. By studying the mechanisms of how the brain fights and removes viruses when they are injected directly into the brain, we hope to identify areas of the infection fighting process that can be changed to improve the viral infection of cancer cells without changing the normal body's ability to fight infection. By doing so, we may be able to use oncolytic therapy with certain drugs that may be able to better treat brain cancer patients.
Competitiondate
200811
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Zemp, Franz J
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~